• Type:
  • Category:

Carl Zeiss Meditec AG Deep Dive 2023 | The Future of Laser Vision Correction with IR

Share

Excerpt

Thu Anh Klimpke, Investor Relations of ZEISS Medical Technology Segment, is presenting a Deep Dive into the revolutionary Zeiss Smile procedure and exploring the future of laser vision correction.

 

This presentation provides an excellent opportunity to learn from Thu Anh, Manager of Investor Relations for the ZEISS Medical Technology Segment, about ZEISS’s leadership in laser vision correction technology.

 

During the presentation, Thu Anh provides valuable insights into ZEISS’s structure and offerings, including the Ophthalmology and Microsurgery strategic business units. She delves into ZEISS’s key focus areas, such as ophthalmic diagnostics, surgical ophthalmology, and refractive laser surgery, and examines the devices and consumables ZEISS offers.

 

The myopia trend and ZEISS’s Smile technology are also discussed, with Thu Anh highlighting the increasing importance of laser vision correction for more and more people.

 

Moreover, attendees will gain valuable insights into the Visa Max 800, a femtosecond system offering outstanding incision precision, speed, and a gentle treatment approach.

Company Profile

The Medical Technology activities of ZEISS are bundled under the umbrella of the MDAX- and TecDAX-listed company Carl Zeiss Meditec AG. 

 

With headquarters in Jena (Germany) and operating sites and subsidiaries in Germany, France, Spain, the USA and Japan the company has a direct presence in the world in major markets. The company can also exploit the Carl Zeiss group`s powerful global distribution network.

 

Two Pillars of Business & Markets:

The main activities of Carl Zeiss Meditec AG are located in the field of Ophthalmology and Microsurgery

In Ophthalmology, the Company offers mainly products and solutions for the diagnosis and treatment of eye diseases, as well as systems and consumables for cataract, retinal and refractive surgery. 

In Microsurgery the Carl Zeiss Meditec Group provides visualization solutions for minimally invasive surgical treatments.

 

Markets:

The Carl Zeiss Meditec Group has operations all over the world. 

With headquarters in Jena (Germany) and operating sites and subsidiaries in Germany, France, Spain, the USA and Japan the company has a direct presence in the world’s most important markets.

 

Milestones & Innovations:

Research and development plays an important role within the Carl Zeiss Meditec Group. 

Our objective is to enable our customers and physicians to continuously improve treatment results through improvements in efficiency and innovative new products

Carl Zeiss Meditec AG

Goeschwitzer Strasse 51-52

Jena 07745, Germany

phone +49 3641 220 116

Chapters

  • Strategic Business Units: Ophthalmology
  • Strategic Business Units: Microsurgery
  • Myopia Trend / Meta Study 
  • Refractive Laser Surgery with Zeiss Smile
  • Zeiss Smile: Devices and Consumables
  • Zeiss Smile: Facts and Figures
  • The Future of Laser Vision Correction

Resources

Host

Thu Anh Klimpke
IR | Carl Zeiss Meditec AG

Sebastian Frericks
Head IR | Carl Zeiss Meditec AG

Share

T&C:

This publication is for informational purposes only and should not be considered investment advice. By using this website, you agree to the terms and conditions outlined in the legal pages at www.seat11a.com/legal/

More Elevator Pitches

More Company Presentations

Reviews for Carl Zeiss Meditec AG Deep Dive 2023 | The Future of Laser Vision Correction with IR

There are currently no reviews for Carl Zeiss Meditec AG Deep Dive 2023 | The Future of Laser Vision Correction with IR
Scroll to top